Reversibility of primary pulmonary hypertension with vasodilator, anticoagulant and nocturnal oxygen therapy

Jpn Heart J. 1989 Nov;30(6):929-34. doi: 10.1536/ihj.30.929.

Abstract

Successful vasodilator therapy of a 19 year old woman with primary pulmonary hypertension is described. Long-term home oxygen therapy during sleep (2 1/min, 8 hours) in combination with vasodilator drugs (prazosin 2 mg and long-acting ISDN 20 mg bid) and an anticoagulant (ticlopidine 100 mg bid) brought significant reduction of pulmonary artery pressure and a rise of cardiac output 3 years later. This combination therapy may be effective in selected patients with primary pulmonary hypertension.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Combined Modality Therapy
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hypertension, Pulmonary / therapy*
  • Isosorbide Dinitrate / therapeutic use*
  • Oxygen Inhalation Therapy*
  • Prazosin / therapeutic use*
  • Ticlopidine / therapeutic use*

Substances

  • Isosorbide Dinitrate
  • Ticlopidine
  • Prazosin